© The Rockefeller University Press,
0021-9525/1997//1395 $5.00
The Journal of Cell Biology, Volume 138, Number 6,
, 1997 1395-1407
Thrombomucin, a Novel Cell Surface Protein that Defines Thrombocytes and Multipotent Hematopoietic Progenitors
Kelly M. McNagny*,
Inger Pettersson*,
Fabio Rossi*,
Ingo Flamme
,
Andrej Shevchenko
,
Matthias Mann
, and
Thomas Graf*
* Cell Regulation Program, and
Protein and Peptide Program, European Molecular Biology Laboratory, Heidelberg, D-69117 Germany; and
Max-Planck Institut for Physiology and Clinical Research, W.G. Kerckhoff-Institute, Department of Molecular Cell Biology, Bad Nauheim, D-61231 Germany
MEP21 is an avian antigen specifically expressed on the surface of Myb-Ets–transformed multipotent hematopoietic precursors (MEPs) and of normal thrombocytes. Using nanoelectrospray tandem mass spectrometry, we have sequenced and subsequently cloned the MEP21 cDNA and named the gene thrombomucin as it encodes a 571–amino acid protein with an extracellular domain typical of the mucin family of proteoglycans. Thrombomucin is distantly related to CD34, the best characterized and most used human hematopoietic stem cell marker. It is also highly homologous in its transmembrane/intracellular domain to podocalyxinlike protein–1, a rabbit cell surface glycoprotein of kidney podocytes.
Single cell analysis of yolk sac cells from 3-d-old chick embryos revealed that thrombomucin is expressed on the surface of both lineage-restricted and multipotent progenitors. In the bone marrow, thrombomucin is also expressed on mono- and multipotent progenitors, showing an overlapping but distinct expression pattern from that of the receptor-type stem cell marker c-kit. These observations strengthen the notion that the Myb-Ets oncoprotein can induce the proliferation of thrombomucin-positive hematopoietic progenitors that have retained the capacity to differentiate along multiple lineages. They also suggest that thrombomucin and CD34 form a family of stem cell–specific proteins with possibly overlapping functions in early hematopoietic progenitors.
Abbreviations used in this paper: cMGF, chicken myelomonocytic growth factor; MEP, Myb-Ets-transformed progenitors; PCLP, podocalyxinlike protein; SCF, stem cell factor.
Please address all correspondence to Thomas Graf, European Molecular Biology Laboratory, D-69117 Heidelberg, Germany. Tel.: 49-62-21-387-411. Fax: 49-62-21-387-516. e-mail: Graf{at}EMBL-Heidelberg.de
Work in M. Mann's laboratory is partially supported by a grant from the German Technology Ministry (BMFT). K.M. McNagny was supported by NRSA Fellowship No. F32 HL0736 from the National Heart, Lung, and Blood Institute, National Institutes of Health, and a grant from the Deutsche Forschungsgemeinschaft (SFB229) to T. Graf.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Nielsen, J. S., McNagny, K. M.
(2009). The Role of Podocalyxin in Health and Disease. J. Am. Soc. Nephrol.
20: 1669-1676
[Abstract]
[Full Text]
-
Nielsen, J. S., McNagny, K. M.
(2008). Novel functions of the CD34 family. J. Cell Sci.
121: 3683-3692
[Abstract]
[Full Text]
-
Pouget, C., Gautier, R., Teillet, M.-A., Jaffredo, T.
(2006). Somite-derived cells replace ventral aortic hemangioblasts and provide aortic smooth muscle cells of the trunk. Development
133: 1013-1022
[Abstract]
[Full Text]
-
Doyonnas, R., Nielsen, J. S., Chelliah, S., Drew, E., Hara, T., Miyajima, A., McNagny, K. M.
(2005). Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells. Blood
105: 4170-4178
[Abstract]
[Full Text]
-
Somasiri, A., Nielsen, J. S., Makretsov, N., McCoy, M. L., Prentice, L., Gilks, C. B., Chia, S. K., Gelmon, K. A., Kershaw, D. B., Huntsman, D. G., McNagny, K. M., Roskelley, C. D.
(2004). Overexpression of the Anti-Adhesin Podocalyxin Is an Independent Predictor of Breast Cancer Progression. Cancer Res.
64: 5068-5073
[Abstract]
[Full Text]
-
Economou, C. G., Kitsiou, P. V., Tzinia, A. K., Panagopoulou, E., Marinos, E., Kershaw, D. B., Kerjaschki, D., Tsilibary, E. C.
(2004). Enhanced podocalyxin expression alters the structure of podocyte basal surface. J. Cell Sci.
117: 3281-3294
[Abstract]
[Full Text]
-
Habermann, B., Oegema, J., Sunyaev, S., Shevchenko, A.
(2004). The Power and the Limitations of Cross-Species Protein Identification by Mass Spectrometry-driven Sequence Similarity Searches. Mol. Cell. Proteomics
3: 238-249
[Abstract]
[Full Text]
-
Fieger, C. B., Sassetti, C. M., Rosen, S. D.
(2003). Endoglycan, a Member of the CD34 Family, Functions as an L-selectin Ligand through Modification with Tyrosine Sulfation and Sialyl Lewis x. J. Biol. Chem.
278: 27390-27398
[Abstract]
[Full Text]
-
McNagny, K. M., Graf, T.
(2003). E26 leukemia virus converts primitive erythroid cells into cycling multilineage progenitors. Blood
101: 1103-1110
[Abstract]
[Full Text]
-
Graf, T.
(2002). Differentiation plasticity of hematopoietic cells. Blood
99: 3089-3101
[Full Text]
-
Koritschoner, N. P., Madruga, J., Knespel, S., Blendinger, G., Anzinger, B., Otto, A., Zenke, M., Bartunek, P.
(2001). The Nuclear Orphan Receptor TR4 Promotes Proliferation of Myeloid Progenitor Cells. Cell Growth Differ.
12: 563-572
[Abstract]
[Full Text]
-
ORLANDO, R. A., TAKEDA, T., ZAK, B., SCHMIEDER, S., BENOIT, V. M., MCQUISTAN, T., FURTHMAYR, H., FARQUHAR, M. G.
(2001). The Glomerular Epithelial Cell Anti-Adhesin Podocalyxin Associates with the Actin Cytoskeleton through Interactions with Ezrin. J. Am. Soc. Nephrol.
12: 1589-1598
[Abstract]
[Full Text]
-
Doyonnas, R., Kershaw, D. B., Duhme, C., Merkens, H., Chelliah, S., Graf, T., McNagny, K. M.
(2001). Anuria, Omphalocele, and Perinatal Lethality in Mice Lacking the Cd34-Related Protein Podocalyxin. JEM
194: 13-28
[Abstract]
[Full Text]
-
Querfurth, E., Schuster, M., Kulessa, H., Crispino, J. D., Doderlein, G., Orkin, S. H., Graf, T., Nerlov, C.
(2000). Antagonism between C/EBPbeta and FOG in eosinophil lineage commitment of multipotent hematopoietic progenitors. Genes Dev.
14: 2515-2525
[Abstract]
[Full Text]
-
Takeda, T., Go, W. Y., Orlando, R. A., Farquhar, M. G.
(2000). Expression of Podocalyxin Inhibits Cell-Cell Adhesion and Modifies Junctional Properties in Madin-Darby Canine Kidney Cells. Mol. Biol. Cell
11: 3219-3232
[Abstract]
[Full Text]
-
Sassetti, C., Van Zante, A., Rosen, S. D.
(2000). Identification of Endoglycan, a Member of the CD34/Podocalyxin Family of Sialomucins. J. Biol. Chem.
275: 9001-9010
[Abstract]
[Full Text]
-
Ody, C., Vaigot, P., Quere, P., Imhof, B. A., Corbel, C.
(1999). Glycoprotein IIb-IIIa Is Expressed on Avian Multilineage Hematopoietic Progenitor Cells. Blood
93: 2898-2906
[Abstract]
[Full Text]
-
Miettinen, A., Solin, M.-L., Reivinen, J., Juvonen, E., Vaisanen, R., Holthofer, H.
(1999). Podocalyxin in Rat Platelets and Megakaryocytes. Am. J. Pathol.
154: 813-822
[Abstract]
[Full Text]
-
Sanchez, M, Gottgens, B, Sinclair, A., Stanley, M, Begley, C., Hunter, S, Green, A.
(1999). An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. Development
126: 3891-3904
[Abstract]
-
Lampisuo, M., Liippo, J., Vainio, O., McNagny, K. M., Kulmala, J., Lassila, O.
(1999). Characterization of prethymic progenitors within the chicken embryo. Int Immunol
11: 63-69
[Abstract]
[Full Text]
-
Nerlov, C., Graf, T.
(1998). PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev.
12: 2403-2412
[Abstract]
[Full Text]
-
Sassetti, C., Tangemann, K., Singer, M. S., Kershaw, D. B., Rosen, S. D.
(1998). Identification of Podocalyxin-like Protein as a High Endothelial Venule Ligand for L-selectin: Parallels to CD34. JEM
187: 1965-1975
[Abstract]
[Full Text]
-
Jaffredo, T, Gautier, R, Eichmann, A, Dieterlen-Lievre, F
(1998). Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development
125: 4575-4583
[Abstract]
-
Li, Y., Li, J., Straight, S. W., Kershaw, D. B.
(2002). PDZ domain-mediated interaction of rabbit podocalyxin and Na+/H+ exchange regulatory factor-2. Am. J. Physiol. Renal Physiol.
282: F1129-F1139
[Abstract]
[Full Text]